Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

Erstveröffentlichung
2011
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Taskesen, Erdogan
Bullinger, Lars
Corbacioglu, Andrea
Sanders, Mathijs A.
Erpelinck, Claudia A. J.
et al.
Institutions
UKU. Klinik für Innere Medizin III
Published in
Blood ; 117 (2011), 8. - S. 2469-2475. - ISSN 0006-4971
Link to publication
https://dx.doi.org/10.1182/blood-2010-09-307280
Funding information
Center for Translational Molecular Medicine
Else Kroner-Fresenius-Stiftung [P38/05//A49/05//F03]
Network of Competence Acute and Chronic Leukemias [01GI9981]
Bundesministerium für Bildung und Forschung, Germany [01KG0605]
Keywords
acute myeloid-leukemia; colony-stimulating factor; binding-protein-alpha; c/ebp-alpha; myelodysplastic syndromes; consolidation therapy; favorable prognosis; normal karyotype; younger adults; trial
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record